Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-16-000138

Options or other derivatives

  • Chief Scientific Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lotze Michael · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-28 Grant or award : show line 1 in the form Stock Option (right to buy) +225,000 $4.54 2026-03-28 225,000 225,000 D
Loading xslF345X03/primary_doc.xml…